ETON PHARMACEUTICALS
Eton Pharmaceuticals is a pharmaceutical company that focuses on developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development. It was founded in 2017 and headquartered in Studio City, California.
ETON PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Studio City, California, United States
Country:
United States
Website Url:
http://www.etonpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Key Employee Changes
Date | New article |
---|---|
2022-04-11 | Eton Pharmaceuticals Names James Gruber Finance Chief |
Official Site Inspections
http://www.etonpharma.com Semrush global rank: 1.42 M Semrush visits lastest month: 19.7 K
- Host name: 149.199.83.34.bc.googleusercontent.com
- IP address: 34.83.199.149
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eton Pharmaceuticals"
Board of Directors | Eton Pharmaceuticals
Notable Experience and Activities. Healthcare leadership roles for over 30 years; Extensive experience leading, transforming, and driving growth in both Fortune 500 public and private equity-backed companies, as well as deep expertise โฆSee details»
Company | Eton Pharmaceuticals
At Eton, we donโt focus on a single therapeutic area or category. Instead, we provide hope by sourcing potential therapies worldwide.See details»
Corporate Profile - Eton Pharmaceuticals, Inc.
21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»
Eton Pharmaceuticals Announces Appointment of Jenn Adams to โฆ
DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โฆSee details»
Eton Pharmaceuticals, Inc. (ETON) - Yahoo Finance Canada
See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Eton Pharmaceuticals - Crunchbase Company Profile
Eton Pharmaceuticals reported its financial results for the fourth quarter and full year 2023, as well as the first quarter of 2024. The company announced the submission of a new drug application to the FDA for ET-400 (Hydrocortisone โฆSee details»
Eton Pharmaceuticals, Inc. (ETON) Company Profile & Facts
See the company profile for Eton Pharmaceuticals, Inc. (ETON) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Investor Relations | Eton Pharmaceuticals, Inc.
Oct 3, 2024 Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million , or $0.02 per diluted share Entered into an asset purchase agreement to acquire Increlex® โฆSee details»
Leadership Team | Eton Pharmaceuticals
Notable Experience. Vice President, US Controller at Horizon Therapeutics, a branded pharmaceutical company where he was responsible for several areas of accounting, finance, and shared services, along with Sarbanes-Oxley โฆSee details»
Bausch Health Acquires Eton Pharmaceuticals' EM-100 โฆ
Feb 19, 2019 For more information, visit www.etonpharma.com. About Bausch + Lomb Bausch + Lomb, a Bausch Health Companies Inc. company, is a leading global eye health โฆSee details»
Mission | Eton Pharmaceuticals
21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»
Eton Pharmaceuticals Reports Record Revenue and Earnings
Mar 31, 2021 To access the conference call, please dial 1-866-795-8473 (domestic) or 1-470-495-9161 (international) and refer to conference ID 5847989. The webcast can be accessed โฆSee details»
Eton Pharmaceuticals Announces Acquisition of Approved
DEER PARK, Ill., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing โฆSee details»
Eton Pharmaceuticals Announces Acquisition of FDA-Approved
Sep 13, 2022 Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral SolutionSee details»
Eton Pharmaceuticals Announces Acquisition of FDA-Approved โฆ
-- Expected to be accretive to 2023 earnings --DEER PARK, Ill., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (โEtonโ or โthe Companyโ) (Nasdaq: ETON), an โฆSee details»
Business Model | Eton Pharmaceuticals
We strive to develop our therapies, file for FDA approval, and launch them with unprecedented speed. Below are a few examples of the types of value Eton tries to unlock:See details»
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to โฆ
Nov 25, 2024 For more information, please visit our website at www.etonpharma.com. Forward-Looking Statements. Statements contained in this press release regarding matters that are not โฆSee details»
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 ...
DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing โฆSee details»
Products | Eton Pharmaceuticals
21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361See details»